Estados Unidos - inglês - NLM (National Library of Medicine)

remedyrepack inc. - fluorometholone (unii: sv0csg527l) (fluorometholone - unii:sv0csg527l) - fluorometholone ophthalmic suspension 0.1% is indicated for the treatment of corticosteroid-responsive inflammation of the palpebral and bulbar conjunctiva, cornea and anterior segment of the globe. fluorometholone ophthalmic suspension 0.1% is contraindicated in most viral diseases of the cornea and conjunctiva, including epithelial herpes simplex keratitis (dendritic keratitis), vaccinia, and varicella, and also in mycobacterial infection of the eye, and fungal diseases of ocular structures. fluorometholone ophthalmic suspension 0.1% is also contraindicated in individuals with known or suspected hypersensitivity to any of the ingredients of this preparation and to other corticosteroids.

Estados Unidos - inglês - NLM (National Library of Medicine)

pacific pharma, inc. - fluorometholone (unii: sv0csg527l) (fluorometholone - unii:sv0csg527l) - fluorometholone ophthalmic suspension 0.1% is indicated for the treatment of corticosteroid-responsive inflammation of the palpebral and bulbar conjunctiva, cornea and anterior segment of the globe. fluorometholone ophthalmic suspension 0.1% is contraindicated in most viral diseases of the cornea and conjunctiva, including epithelial herpes simplex keratitis (dendritic keratitis), vaccinia, and varicella, and also in mycobacterial infection of the eye, and fungal diseases of ocular structures. fluorometholone ophthalmic suspension 0.1% is also contraindicated in individuals with known or suspected hypersensitivity to any of the ingredients of this preparation and to other corticosteroids.

Estados Unidos - inglês - NLM (National Library of Medicine)

amneal pharmaceuticals ny llc - fluorometholone (unii: sv0csg527l) (fluorometholone - unii:sv0csg527l) - fluorometholone ophthalmic suspension is indicated for the treatment of corticosteroid-responsive inflammation of the palpebral and bulbar conjunctiva, cornea and anterior segment of the globe. fluorometholone ophthalmic suspension is contraindicated in most viral diseases of the cornea and conjunctiva, including epithelial herpes simplex keratitis (dendritic keratitis), vaccinia, and varicella, and also in mycobacterial infection of the eye, and fungal diseases of ocular structures. fluorometholone ophthalmic suspension is also contraindicated in individuals with known or suspected hypersensitivity to any of the ingredients of this preparation and to other corticosteroids.

Estados Unidos - inglês - NLM (National Library of Medicine)

alcon laboratories, inc. - fluorometholone acetate (unii: 9i50c3i3ok) (fluorometholone - unii:sv0csg527l) - fluorometholone acetate 1 mg in 1 ml - flarex (fluorometholone acetate ophthalmic suspension) is indicated for use in the treatment of steroid responsive inflammatory conditions of the palpebral and bulbar conjunctiva, cornea, and anterior segment of the eye. contraindicated in acute superficial herpes simplex keratitis, vaccinia, varicella, and most other viral diseases of cornea and conjunctiva; mycobacterial infection of the eye; fungal diseases; acute purulent untreated infections, which like other diseases caused by microorganisms, may be masked or enhanced by the presence of the steroid; and in those persons who have known hypersensitivity to any component of this preparation.

Canadá - inglês - Health Canada

pharmascience inc - fluorometholone - suspension - 0.1% - fluorometholone 0.1% - corticosteroids

Estados Unidos - inglês - NLM (National Library of Medicine)

novartis ophthalmics - fluorometholone (unii: sv0csg527l) (fluorometholone - unii:sv0csg527l) - suspension - 0.1 ml in 100 ml - fluor-op is indicated for the treatment of corticosteroid-responsive inflammation of the palpebral and bulbar conjunctiva, cornea and anterior segment of the globe. fluor-op suspension is contraindicated in most viral diseases of the cornea and conjunctiva, including epithelial herpes simplex keratitis (dendritic keratitis), vaccinia, and varicella, and also in mycobacterial infection of the eye and fungal diseases of ocular structures. fluor-op suspension is also contraindicated in individuals with known or suspected hypersensitivity to any of the ingredients of this preparation and to other corticosteroids.

Estados Unidos - inglês - NLM (National Library of Medicine)

eyevance pharmaceuticals - fluorometholone acetate (unii: 9i50c3i3ok) (fluorometholone - unii:sv0csg527l) - flarex (fluorometholone acetate ophthalmic suspension) 0.1% is indicated for use in the treatment of steroid responsive inflammatory conditions of the palpebral and bulbar conjunctiva, cornea, and anterior segment of the eye. contraindicated in acute superficial herpes simplex keratitis, vaccinia, varicella, and most other viral diseases of cornea and conjunctiva; mycobacterial infection of the eye; fungal diseases; acute purulent untreated infections, which like other diseases caused by microorganisms, may be masked or enhanced by the presence of the steroid; and in those persons who have known hypersensitivity to any component of this preparation.

Canadá - inglês - Health Canada

sandoz canada incorporated - fluorometholone - suspension - 0.1% - fluorometholone 0.1% - corticosteroids

Estados Unidos - inglês - NLM (National Library of Medicine)

allergan, inc. - fluorometholone (unii: sv0csg527l) (fluorometholone - unii:sv0csg527l), sulfacetamide sodium (unii: 4nrt660kjq) (sulfacetamide - unii:4965g3j0f5) - suspension - 1.0 mg in 1 ml - fml-s® ophthalmic suspension is indicated for steroid-responsive inflammatory ocular conditions for which a corticosteroid is indicated and where superficial bacterial ocular infection or a risk of bacterial ocular infection exists. ocular steroids are indicated in inflammatory conditions of the palpebral and bulbar conjunctiva, cornea and anterior segment of the globe, where the inherent risk of steroid use in certain infective conjunctivitides is accepted to obtain a diminution in edema and inflammation. they are also indicated in chronic anterior uveitis and corneal injury from chemical, radiation or thermal burns or penetration of foreign bodies. the use of a combination drug with an anti-infective component is indicated where the risk of superficial ocular infection is high or where there is an expectation that potentially dangerous numbers of bacteria will be present in the eye. the anti-infective drug in this product, sulfacetamide, is active against the following common bacterial eye pathogens: esche

Austrália - inglês - Department of Health (Therapeutic Goods Administration)

abbvie pty ltd - fluorometholone, quantity: 1 mg/ml - eye drops, suspension - excipient ingredients: benzalkonium chloride; disodium edetate; sodium chloride; monobasic sodium phosphate; dibasic sodium phosphate heptahydrate; polysorbate 80; sodium hydroxide; purified water; polyvinyl alcohol - indications as at 23 oct 1995 : for steroid responsive inflammation of the palpebral and bulbar conjunctiva, cornea and anterior segment of the globe.